The systolic hypertension in the elderly program. Implications for nursing practice and research

Area of Science:

• Gerontology
• Cardiovascular Medicine
• Clinical Trials

Background:

• Isolated systolic hypertension (ISH) is prevalent in elderly individuals.
• ISH increases the risk of stroke, cardiovascular disease, and mortality.
• Effective antihypertensive therapy is needed to mitigate these risks in older adults.

Purpose of the Study:

• To investigate the safety and efficacy of antihypertensive therapy in patients aged 60 years and over with ISH.
• To establish recommendations for effective therapy that preserves quality of life and reduces long-term risks.
• To describe the design, protocol, and organization of the SHEP pilot and full-scale trials.

Main Methods:

• The Systolic Hypertension in the Elderly Program (SHEP) involved a pilot study and a full-scale clinical trial.
• Participants were patients aged 60+ with isolated systolic hypertension (systolic blood pressure ≥ 160 mmHg, diastolic blood pressure < 90 mmHg).
• Nurses were integral to protocol planning, patient recruitment, care, compliance, data collection, and reporting.

Main Results:

• The SHEP trials aimed to provide evidence for effective antihypertensive treatment in elderly ISH patients.
• Optimal results would inform therapy recommendations to improve patient outcomes and reduce cardiovascular risks.
• Detailed descriptions of trial design and nursing roles are provided.

Conclusions:

• The SHEP trials are crucial for understanding and managing isolated systolic hypertension in the elderly.
• The study highlights the significant contributions of nurses in conducting multicenter clinical trials.
• Findings are expected to guide clinical practice and reduce adverse cardiovascular events in older populations.